• Info
  • Insider Ownership

Insider Trading & Ownership of Douglas G. Cole

Location
Cambridge, MA
Summary
The estimated net worth of Douglas G. Cole is at least $609,059 dollars as of 17 Jun 2025. Douglas G. Cole is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $489.3K. Douglas G. Cole is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $119.8K.
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Douglas G. Cole
All Insider Reports
All Insider Reports

Notify me when Douglas G. Cole files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Douglas G. Cole

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $489,309 01 Jun 2023
FHTX Foghorn Therapeutics Inc. Director $119,750 17 Jun 2025
SANA Sana Biotechnology, Inc. Director 06 Jun 2024
SGTX Sigilon Therapeutics, Inc. Director 11 Aug 2023

Insider Transactions Reported by Douglas G. Cole:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.